Interaction of platelets with liposomes containing dodecapeptide sequence from fibrinogen

Thrombosis and Haemostasis

Volumn 91, Issue 6, 2004, Pages 1158-1167

  Nishiya, Takako ^a   Toma, Chikaho ^a  

^a FUJIREBIO INC   (Japan)

Author keywords

Dodecapeptide; Liposome platelet interaction; Octa arginine; Peptide conjugated liposome; Platelet substitute

Indexed keywords

ARGININE DERIVATIVE; COLLAGEN; FIBRINOGEN; LIGAND; LIPID; LIPOSOME; PEPTIDE DERIVATIVE; PHOSPHATIDYLETHANOLAMINE;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; CONJUGATION; CONTROLLED STUDY; DENSITY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; INTERNALIZATION; LIGAND BINDING; MEASUREMENT; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

EID: 3042673593     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/th03-10-0615     Document Type: Article

References (51)

1. Alving CR, Steck EA, Chapman Jr WL, et al. Liposomes in leishmaniasis: Therapeutic effects of antimonial drugs, 8-aminoquinolines, and tetracycline. Life Sci 1980; 26: 2231-8.
2. Fidler IJ, Sone S, Fogler WE, et al. Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci USA 1981; 78: 1680-4.
3. Proffitt RT, Williams LE, Presant CA, et al. Liposomal blockade of the reticuloendothelial system: Improved tumor imaging with small unilamellar vesicle. Science 1983; 220: 502-5.
4. Hunt CA, Rusturn YM, Mayhew E, et al. Retention of cytosine arabinoside in mouse lung following intravenous administration in liposomes of different size. Drug Metab Dispos 1979; 7: 124-8.
5. Leserman L. Side chains and magic bullets: Paul Ehrlich revisited, in: G. Gregoriadis (Ed.), Liposomes as drug carriers: Recent trends and progress. Wiley, Chichester, 1988; 719-26.
6. Connor J, Huang L. Efficient cytoplasmic delivery of a fluorescent dye by pH-sensitive immunoliposomes. J Cell Biol 1985; 101: 582-9.
7. Sullivan SM, Huang L. Preparation and characterization of heat-sensitive immunoliposomes. Biochim Biophys Acta 1985; 812: 116-26.
8. Saiki I, Koike C, Obata A, et al. Functional role of sialyl Lewis X and fibronectin-derived RGDS peptide analogue on tumor-cell arrest in lung followed by extravasation. Int J Cancer 1996; 65: 833-9.
9. Oku N, Tokudome Y, Koike C, et al. Liposomal RGD analogues effectively inhibit metastatic B16 melanoma colonization in murine lungs. Life Sci 1996; 58: 2263-70.
10. Oku N, Koike C, Tokudome Y, et al. Application of liposomes for cancer metastasis. Adv Drug Deliv Rev 1997; 24: 215-23.
11. Savage B, Ruggeri ZM. Selective recognition of adhesive sites in surface-bound fibrinogen by glycoprotein IIb-IIIa on nonactivated platelets. J Biol Chem 1991; 266: 11227-33.
12. Savage B, Shattil SJ, Ruggeri ZM. Modulation of platelet function through adhesion receptors. J Biol Chem 1992; 267: 11300-6.
13. Marguerie GA, Plow EF, Edgington TS. Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem 1979; 254: 5357-63.
14. Ruggeri ZM, De Marco L, Gatti L, et al. Platelets have more than one binding site for von Willebrand factor. J Clin Invest 1983; 72: 1-12.
15. Mustard JF, Packham MA, Kinlough-Rathbone RL, et al. Fibrinogen and ADP-induced platelet aggregation. Blood 1978; 52: 453-66.
16. De Marco L, Girolami A, Zimmerman TS, et al. von Willebrand factor interaction with the glycoprotein IIb/IIIa complex. J Clin Invest 1986; 77: 1272-7.
17. Hawiger J, Timmons S, Kloczewiak M, et al. γ and α chains of human fibrinogen possess sites reactive with human platelet receptors, Proc Natl Acad Sci USA 1982; 79: 2068-71.
18. Kloczewiak M, Timmons S, Lukas T, et al. Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the γ chain. Biochemistry 1984; 23: 1767-74.
19. Pytela R, Pierschbacher MD, Ginsberg MH, et al. Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp-specific adhesion receptors. Science 1986; 231: 1559-62.
20. Lam SC-T, Plow EF, Smith MA, et al. Evidence that arginyl-glycyl-aspartate peptides and fibrinogen γ chain peptides share a common binding site on platelets. J Biol Chem 1987; 262: 947-50.
21. Green M, Loewenstein PM. Autonomous functional domains of chemically synthesized human immunodeficiency virus Tat trans-activator protein. Cell 1988; 55: 1179-88.
22. Frankel AD, Pabo CO. Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 1988; 55: 1189-93.
23. Vocero-Akbani A, Lissy NA, Dowdy SF. Transduction of full-length Tat fusion proteins directly into mammalian cells: Analysis of T cell receptor activation-induced cell death. Methods Enzymol 2000; 322: 508-21.
24. Verhoef K, Koken SEC, Berkhout B. Electroporation of the HIV Tat trans-activator protein into cells. Anal Biochem 1993; 210: 210-4.
25. Joliot A, Pernelle C, Deagostini-Bazin H, Prochiantz A. Antennapedia homeobox peptide regulates neutral morphogenesis. Proc Natl Acad Sci USA 1991; 88: 1864-8.
26. Elliot G, O'Hare P. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 1997; 88: 223-33.
27. Fawell S, Seery J, Daikh Y, et al. Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci USA 1994; 91: 664-8.
28. Astriab-Fisher A, Sergueev DS, Fisher M, et al. Antisense inhibition of P-glycoprotein expression using peptide-oligonucleotide conjugates. Biochem Pharmacol 2000; 60: 83-90.
29. Polyakov V, Sharma V, Dahlheimer JL, et al. Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy. Bioconjugate Chem 2000; 11: 762-71.
30. Lewin M, Carlesso N, Tung CH, et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nature Biotechnol 2000; 18: 410-4.
31. Torchilin VP, Rammohan R, Weissig V, et al. Tat peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc Natl Acad Sci USA 2001; 98: 8786-91.
32. Futaki S, Suzuki T, Ohashi W, et al. Arginine-rich peptides: An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery, J Biol Chem 2001; 276: 5836-40.
33. Wender PA, Mitchell DJ, Pattabiraman K, et al. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid molecular transporters. Proc Natl Acad Sci USA 2000; 97: 13003-8.
34. Szoka Jr F, Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci USA 1978; 75: 4194-8.
35. Hope MJ, Bally MB, Webb G, et al. Production of large unilamellar vesicles by a rapid extrusion procedure: Characterization of size, trapped volume and ability to maintain a membrane potential. Biochim Biophys Acta 1985; 12: 55-65.
36. Daleke DL, Hong K, Papahadjopoulos D. Endocytosis of liposomes by macrophages: Binding, acidification and leakage of liposomes monitored by a new fluorescence assay. Biochim Biophys Acta 1990; 1024: 352-66.
37. Ozaki Y, Satoh K, Yatomi Y, et al. Detection of platelet aggregates with a particle counting method using light scattering. Anal Biochem 1994; 218: 284-94.
38. Yamamoto T, Egawa Y, Shirasawa Y, et al. A laser light scattering in situ system for counting aggregates in blood platelet aggregation. Meas Sci Technol 1995; 6: 174-80.
39. Struck DK, Hoekstra D, Pagano RE. Use of resonance energy transfer to monitor membrane fusion. Biochemistry 1981; 20: 4093-9.
40. Lestini BL, Sagnella SM, Xu Z, et al. Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery. J Control Release 2002; 78: 235-47.
41. Nishiya T, Murata M, Handa M, et al. Targeting of liposomes carrying recombinant fragments of platelet membrane glycoprotein Ibα to immobilized von Willebrand factor under flow conditions. Biochem Biophys Res Commun 2000; 270: 755-60.
42. Nishiya T, Kainoh M, Murata, et al. Platelet interaction with liposomes carrying recombinant platelet membrane glycoproteins or fibrinogen: approach to platelet substitutes. Art Cells Blood Subs Immob Biotech 2001; 29: 453-64.
43. Nishiya T, Kainoh M, Murata, et al. Reconstitution of adhesive properties of human platelets in liposomes carrying both recombinant glycoproteins Ia/IIa and Ibα under flow condition: specific synergy of receptor-ligand interactions. Blood 2002; 100: 136-42.
44. Rand R, Tinker DO, Fast PG. Polymorphism of phosphatidylethanolamines from two natural sources. Chem Phys Lipids 1971; 6: 333-42.
45. Ho RJY, Huang L. Interactions of hapten sensitized liposomes with immobilized antibody: a homogeneous solid-phage immunoliposome assay. Biophys J 1985; 47: 495a.
46. Ho RJY, Huang L. Interactions of antigen-sensitized liposomes with immobilized antibody: a homogeneous solid-phase immunoliposome assay. J Immunology 1985; 134: 4035-40.
47. Derossi D, Chassaing G, Prochiantz A. Trojan peptides: the penetration system for intracellular delivery. Trends Cell Biol 1998; 8: 84-7.
48. White JG. Uptake of latex particles by blood platelets. Am J Pathol 1972; 69: 439-50.
49. Male R, Vannier WE, Baldeschwieler JD. Phagocytosis of liposomes by human platelets. Proc Natl Acad Sci USA 1992; 89: 9191-5.
50. Ntziachristos V, Tung C, Bremer C, et al. Fluorescence-mediated tomography resolves protease activity in vivo. Nat Med 2002; 8: 757-61.
51. Ntziachristos V, Weissleder R. Charge-coupled-device based scanner for tomography of fluorescent near-infrared probes in turbid media. Med Phys 2002; 29: 803-9.